跳至主要内容
临床试验/CTRI/2025/09/095268
CTRI/2025/09/095268
尚未招募
3 期

CLINICAL EVALUATION OF BRAHMI GHRITA MATRA BASTI AND BRAHMI GHRITA ORALLY IN AUTISM

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年10月7日最近更新:

概览

阶段
3 期
状态
尚未招募
发起方
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
入组人数
60
试验地点
1
主要终点
1. Assess improvement in core symptoms of ASD using CARS.

概览

简要总结

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with impaired communication, restricted interests, and repetitive behaviors. Current medicines only manage associated symptoms and have side effects. Ayurveda describes a similar condition under Unmada. Brahmi Ghrita is a classical Medhya Rasayana useful for cognition, memory, and speech, while Matra Basti is beneficial in Vata Vyadhi.

This randomized comparative clinical study will evaluate oral Brahmi Ghrita versus Brahmi Ghrita Matra Basti with oral administration in 60 children (3–12 years) diagnosed with ASD as per DSM-V criteria. Group A will receive oral Brahmi Ghrita for 30 days; Group B will receive Matra Basti for 7 days followed by oral administration for 23 days.

Efficacy will be assessed using the Childhood Autism Rating Scale (CARS) and Aberrant Behavior Checklist (ABC). The study aims to establish a safe, cost-effective Ayurvedic intervention for Autism Spectrum Disorder.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • 1.Diagnosed cases of Autism satisfying DSM V Criteria.
  • 2.Children from 3 to 12 years, irrespective of gender, religion.
  • 3.Parents / guardian willing to give informed written consent to participate in the study.

排除标准

  • i.Patients having mental retardation, cerebral palsy, seizures, epilepsy.
  • ii.Patients having presence of other organic or psychotic neurological disorder.
  • iii.Patients having hearing and visual impairment.
  • Patients having acute and chronic systemic illness such as renal diseases, hepatic dysfunction, juvenile diabetes mellitus etc.
  • Patients having any other congenital disorders.

结局指标

主要结局

1. Assess improvement in core symptoms of ASD using CARS.

时间窗: 1. DAY 7 OF TREATMENT | 2. DAY 15 OF TREATMENT | 3. DAY 30 OF TREATMENT | 4. DAY 45 AFTER TREATMENT

2. Assess behavioral improvement using ABC.

时间窗: 1. DAY 7 OF TREATMENT | 2. DAY 15 OF TREATMENT | 3. DAY 30 OF TREATMENT | 4. DAY 45 AFTER TREATMENT

3. Compare oral Brahmi Ghrita with Brahmi Ghrita Matra Basti plus oral administration.

时间窗: 1. DAY 7 OF TREATMENT | 2. DAY 15 OF TREATMENT | 3. DAY 30 OF TREATMENT | 4. DAY 45 AFTER TREATMENT

次要结局

  • A BETTER MANAGEMENT OUTCOMES IN AUTISM THROUGH BIOLOGICAL METHODS(15 DAYS)

研究者

发起方
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

MONIKA

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

研究点 (1)

Loading locations...

相似试验